Filter
2151
Filtered Results: 2151
Text search:
World
Health
Organization,
Regional
Office
for
the
Americas
Featured
Recommendations
217
New Publications
461
Language
Document type
No document type
1001
Studies & Reports
521
Guidelines
295
Manuals
153
Strategic & Response Plan
79
Training Material
45
Situation Updates
22
Fact sheets
20
Resource Platforms
9
Infographics
3
Online Courses
2
App
1
Countries / Regions
Global
168
Latin America and the Carribbean
81
Western and Central Europe
39
India
33
Africa
29
Liberia
23
Syria
22
Venezuela
22
Ethiopia
22
South Africa
21
Ukraine
18
Sierra Leone
18
Haiti
18
Uganda
17
Asia
16
Eastern Europe
16
South–East Asia Region
15
Myanmar / Burma
15
Nigeria
14
South Sudan
14
Colombia
13
Kenya
13
Middle East and North Africa
13
Russia
13
Zambia
13
Ghana
12
Philippines
12
Tanzania
12
Brazil
12
Bangladesh
11
Nepal
10
Afghanistan
9
West and Central Africa
9
Eastern Europe and Central Asia
9
Namibia
9
Thailand
8
Rwanda
8
Guinea
8
Congo, Democratic Republic of
8
East and Southern Africa
8
Malawi
7
Zimbabwe
7
Indonesia
7
Pakistan
7
China
6
Peru
6
Mozambique
6
Cambodia
6
Jordan
6
Paraguay
6
Somalia
6
Ecuador
6
Iran
5
Senegal
4
USA
4
Germany
4
Western Pacific Region
4
North America
4
Lebanon
4
Iraq
4
Eswatini/ Swaziland
4
Tajikistan
3
Mexico
3
Albania
3
Papua New Guinea
3
Moldova
3
Yemen
3
Greece
3
Central African Republic
3
Honduras
3
Mali
3
Botswana
3
Madagascar
3
North Macedonia
2
El Salvador
2
Lesotho
2
Chile
2
Canada
2
Estonia
2
Kyrgyzstan
2
Armenia
2
Dominican Republic
2
Jamaica
2
Southern Africa
2
Bolivia
2
Argentina
2
Vietnam
2
Sudan
2
Romania
2
Palestine
2
Georgia
2
Libya
2
Guatemala
2
North Korea
1
Timor Leste/ East Timor
1
Turkey
1
Kazakhstan
1
Cameroon
1
Laos
1
Niger
1
Burkina Faso
1
Malaysia
1
Vanuatu
1
Morocco
1
Mongolia
1
Qatar
1
Guinea-Bissau
1
Cape Verde
1
Croatia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Belgium
1
Tunisia
1
United Kingdom
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Poland
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
396
Clinical Guidelines
230
Women & Child Health
164
Public Health
161
Key Resources
158
Capacity Building
43
Pharmacy & Technologies
28
Toolboxes
Mental Health
211
HIV
202
COVID-19
168
Planetary Health
134
Rapid Response
107
TB
92
Disability
89
NTDs
85
Global Health Education
72
Zika
65
AMR
63
Caregiver
62
Refugee
54
Conflict
48
NCDs
45
Pharmacy
38
Health Financing Toolbox
37
Ebola & Marburg
34
Natural Hazards
31
Malaria
27
Specific Hazards
14
Polio
10
Cholera
7
Social Ethics
7
2.0 Rapid Response
3
Typhoon
2
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonou...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI...
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of new treatment guidelines and feedback from partners following
the 2011 version. In alignment with the UN Global strategy f...
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
- The goal of diagnostic testing for Ebola and Marburg virus diseases is to identify cases to provide timely and appropriate care and to stop disease transmission.
- All individuals meeting the case definition for Ebola or Marburg virus diseases should be tested.
- The recommended sample type ...
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-frie...
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the WHO-ITU Global standard for accessibility of telehealth services. The toolkit is...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective trea...
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a...
When setting national drinking-water quality regulations and standards, many countries consider the WHO Guidelines for drinking-water quality (GDWQ). To better understand the extent to which the GDWQ are used and reflected in these standards, this global review summarizes information from 104...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
This participants’ guide is part of a five-part Caregiver skills training for families of children with developmental delays or disabilities (CST) package providing guidance on caregiver skills training for families of children aged 2–9 years with developmental delays or disabilities.
This pa...
